Silihan lan utang jangka dawa perusahaan: BioHarvest (BHST)

The price evolution of BioHarvest Sciences (BHST) on the GURU.Markets platform demonstrates the 0.01 metric, as the business transitions to a production scale-up phase through global contracts with market leaders. This development relies on a staff of experts attracted by the ecological approach to plant cell synthesis and stock option programs. However, success depends on competing with pharma behemoths implementing low-cost biotechnologies.

This indicator measures the total volume of liabilities with a maturity of more than one year, reflecting the issuer's financing strategy and debt load. For BioHarvest Sciences (BHST), this parameter determines the ability to scale Israeli bioreactors without risking insolvency. By analyzing the firm's current level of long-term borrowings, an investor assesses the balance between aggressive growth and financial stability. The trend of this metric serves as a signal regarding the business's degree of dependence on external capital.